Depression Ups Readmission Odds for COPD Exacerbation

Share this content:
Depression Ups Readmission Odds for COPD Exacerbation
Depression Ups Readmission Odds for COPD Exacerbation

WEDNESDAY, Dec. 2, 2015 (HealthDay News) -- Depression is independently associated with increased risk of readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD), according to a study published online Nov. 24 in the Annals of the American Thoracic Society.

Anand S. Iyer, M.D., from the University of Alabama at Birmingham, and colleagues characterized the association between depression and anxiety and COPD remission risk. Medical records were examined for 422 patients with a primary diagnosis of acute exacerbation of COPD admitted between November 2010 and October 2012. Factors associated with readmission were assessed at one year and within 30 and 90 days.

The researchers found that 132 patients were readmitted in one year. Readmitted patients had lower percent predicted forced expiratory volume in one second (P = 0.05) and higher frequency of depression (P < 0.001), on univariate analysis. Independent associations were seen for one-year readmission with depression (adjusted odds ratio, 2.67) and in-hospital tobacco cessation counseling (adjusted odds ratio, 0.34), in multivariable analysis. Depression also predicted readmission at 30 and 90 days (adjusted odds ratios, 3.83 and 2.47, respectively).

"Depression is an independent risk factor for both short- and long-term readmissions for acute exacerbation of COPD and may represent a modifiable risk factor," the authors write. "In-hospital tobacco cessation counseling was also associated with reduced one-year readmission."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »